1. Home
  2. KRYS vs MC Comparison

KRYS vs MC Comparison

Compare KRYS & MC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRYS
  • MC
  • Stock Information
  • Founded
  • KRYS 2015
  • MC 2007
  • Country
  • KRYS United States
  • MC United States
  • Employees
  • KRYS N/A
  • MC N/A
  • Industry
  • KRYS Biotechnology: Biological Products (No Diagnostic Substances)
  • MC Investment Managers
  • Sector
  • KRYS Health Care
  • MC Finance
  • Exchange
  • KRYS Nasdaq
  • MC Nasdaq
  • Market Cap
  • KRYS 3.6B
  • MC 4.2B
  • IPO Year
  • KRYS 2017
  • MC 2014
  • Fundamental
  • Price
  • KRYS $133.05
  • MC $56.58
  • Analyst Decision
  • KRYS Strong Buy
  • MC Hold
  • Analyst Count
  • KRYS 8
  • MC 7
  • Target Price
  • KRYS $211.13
  • MC $59.83
  • AVG Volume (30 Days)
  • KRYS 320.8K
  • MC 722.9K
  • Earning Date
  • KRYS 08-04-2025
  • MC 07-23-2025
  • Dividend Yield
  • KRYS N/A
  • MC 4.59%
  • EPS Growth
  • KRYS 109.01
  • MC N/A
  • EPS
  • KRYS 4.16
  • MC 2.29
  • Revenue
  • KRYS $333,448,000.00
  • MC $1,283,653,000.00
  • Revenue This Year
  • KRYS $44.05
  • MC $10.42
  • Revenue Next Year
  • KRYS $46.15
  • MC $19.33
  • P/E Ratio
  • KRYS $31.77
  • MC $24.74
  • Revenue Growth
  • KRYS 247.53
  • MC 45.14
  • 52 Week Low
  • KRYS $122.80
  • MC $47.00
  • 52 Week High
  • KRYS $219.34
  • MC $82.89
  • Technical
  • Relative Strength Index (RSI)
  • KRYS 44.16
  • MC 47.40
  • Support Level
  • KRYS $127.99
  • MC $55.80
  • Resistance Level
  • KRYS $143.20
  • MC $58.91
  • Average True Range (ATR)
  • KRYS 4.23
  • MC 1.29
  • MACD
  • KRYS 1.01
  • MC -0.25
  • Stochastic Oscillator
  • KRYS 44.48
  • MC 25.43

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

About MC Moelis & Company

Moelis & Co is an independent investment bank that provides strategic and financial advice to a diverse client base, including corporations, financial sponsors, governments, and sovereign wealth funds. The company assists its clients in achieving their strategic goals by offering comprehensive, globally integrated financial advisory services across all industry sectors. It also advises clients on their critical decisions, including mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters. it generates revenue from advisory transactions. The firm derives a majority of its revenue from the United States followed by Europe and the rest of the World.

Share on Social Networks: